[go: up one dir, main page]

CY1110910T1 - Νεα θεραπευτικη χρηση για μια ομαδα σουλφωμενων πολυσακχαριτων - Google Patents

Νεα θεραπευτικη χρηση για μια ομαδα σουλφωμενων πολυσακχαριτων

Info

Publication number
CY1110910T1
CY1110910T1 CY20101101018T CY101101018T CY1110910T1 CY 1110910 T1 CY1110910 T1 CY 1110910T1 CY 20101101018 T CY20101101018 T CY 20101101018T CY 101101018 T CY101101018 T CY 101101018T CY 1110910 T1 CY1110910 T1 CY 1110910T1
Authority
CY
Cyprus
Prior art keywords
sulphate
inulin
group
sulfished
polysakhars
Prior art date
Application number
CY20101101018T
Other languages
English (en)
Inventor
Pahi Francisco Javier Vila
Ferrer Josep Escaich
August Lodewijk Verbruggen
Milano Josep Verges
Roura Ramon Ruhi
Verson Carlos Raul Alaez
Original Assignee
Bioiberica, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioiberica, S.A. filed Critical Bioiberica, S.A.
Publication of CY1110910T1 publication Critical patent/CY1110910T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται στη χρήση ενός σουλφωμένου πολυσακχαρίτη υπό όξινη μορφή ή ως φυσιολογικώς αποδεκτό άλας του, που επιλέγεται από την ομάδα που αποτελείται από θειική ινουλίνη, θειική ζελλάνη, θειική πουλλουλάνη, θειική κουρδλάνη, θειικό αλγινικό οξύ, θειική λαμιναρίνη και θειική πηκτίνη, για την παρασκευή φαρμάκου για τη θεραπεία ή προφύλαξη από άρθρωση σε ένα θηλαστικό. Κατά προτίμηση, ο σουλφωμένος πολυσακχαρίτης είναι η θειική ινουλίνη, όλως προτιμώμενα το άλας νατρίου της πολυθειικής ινουλίνης. Η παρούσα εφεύρεση αναφέρεται επίσης στη χρήση ενός σουλφωμένου ολιγοσακχαρίτη που παράγεται από ένα πολυσακχαρίτη επιλεγόμενο από την ομάδα που αποτελείται από ινουλίνη, ζελλάνη, πουλλουλάνη. κουρδλάνη, αλγινικό οξύ, λαμιναρίνη και πηκτίνη, για την παρασκευή φαρμάκου για τη θεραπεία ή προφύλαξη από άρθρωση σε ένα θηλαστικό.
CY20101101018T 2004-02-27 2010-11-11 Νεα θεραπευτικη χρηση για μια ομαδα σουλφωμενων πολυσακχαριτων CY1110910T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200400464A ES2251289B1 (es) 2004-02-27 2004-02-27 Nuevo uso terapeutico de un grupo de polisacaridos sulfatados.
EP05707336A EP1917018B1 (en) 2004-02-27 2005-02-11 Inulin sulphate for the treatment of osteoarthritis

Publications (1)

Publication Number Publication Date
CY1110910T1 true CY1110910T1 (el) 2015-06-10

Family

ID=34917281

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101018T CY1110910T1 (el) 2004-02-27 2010-11-11 Νεα θεραπευτικη χρηση για μια ομαδα σουλφωμενων πολυσακχαριτων

Country Status (15)

Country Link
US (1) US7816329B2 (el)
EP (1) EP1917018B1 (el)
JP (1) JP2007523925A (el)
AT (1) ATE484285T1 (el)
AU (1) AU2005218729A1 (el)
CA (1) CA2555616A1 (el)
CY (1) CY1110910T1 (el)
DE (1) DE602005024186D1 (el)
DK (1) DK1917018T3 (el)
ES (2) ES2251289B1 (el)
NZ (1) NZ549989A (el)
PL (1) PL1917018T3 (el)
PT (1) PT1917018E (el)
SI (1) SI1917018T1 (el)
WO (1) WO2005084610A2 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5002937B2 (ja) * 2005-10-03 2012-08-15 Ｊｎｃ株式会社 硫酸化多糖及びその製造法
ES2327480B1 (es) * 2007-06-15 2010-08-10 Bioiberica, S.A. "disacaridos para el tratamiento de tendones, ligamentos y huesos".
US10927193B2 (en) 2015-12-22 2021-02-23 Stemmatters, Biotecnologia E Medicina Regenerativa Gellan gum-based hydrogels, methods and uses thereof
RU2686075C1 (ru) * 2018-04-11 2019-04-24 Дмитрий Вениаминович Воробьев Биологически активное средство для лечения заболеваний опорно-двигательной системы и способ лечения заболеваний опорно-двигательной системы
WO2021211441A1 (en) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Modified sugar polymers with low anticoagulant activity and therapeutic activity
CN113730646A (zh) * 2021-08-27 2021-12-03 中国海洋大学 一种高载药可降解褐藻酸硫酸酯血管栓塞微球及其制备方法和应用
CN116179630A (zh) * 2021-11-26 2023-05-30 中国科学院大连化学物理研究所 一种化学修饰的聚糖衍生物及其制备和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2686779A (en) 1949-07-18 1954-08-17 Phillips Petroleum Co Process for producing alkali metal sulfates of cellulose, inulin, dextrin, and starch
US4021545A (en) * 1976-07-12 1977-05-03 American Cyanamid Company Complement inhibitors
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
WO1988007060A1 (en) * 1987-03-19 1988-09-22 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5063210A (en) 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
AU1154992A (en) * 1991-01-30 1992-09-07 Hoechst Aktiengesellschaft Use of substituted polysaccharides for the treatment of degenerative articular ailments
JP2844396B2 (ja) 1991-02-07 1999-01-06 ポーラ化成工業株式会社 化粧料
CA2060223C (en) 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
US5407581A (en) * 1992-03-17 1995-04-18 Asahi Medical Co., Ltd. Filter medium having a limited surface negative charge for treating a blood material
WO2001021008A2 (en) * 1999-09-22 2001-03-29 Societe Des Produits Nestle S.A. Method for increasing pet activity
FR2816213B1 (fr) * 2000-11-03 2005-04-22 Goemar Lab Sa Medicament anti-inflammatoire et cicatrisant
JP2005521379A (ja) * 2001-07-13 2005-07-21 イムクローン システムズ インコーポレイティド ヘパラナーゼ活性を阻害するための方法及び組成物
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
ES2297516T3 (es) 2003-12-02 2008-05-01 Universiteit Gent Uso de alginato polisulfatado en matrices celulares.

Also Published As

Publication number Publication date
ATE484285T1 (de) 2010-10-15
ES2251289B1 (es) 2007-07-01
WO2005084610A2 (en) 2005-09-15
CA2555616A1 (en) 2005-09-15
PL1917018T3 (pl) 2011-03-31
EP1917018B1 (en) 2010-10-13
US7816329B2 (en) 2010-10-19
NZ549989A (en) 2008-10-31
US20080051350A1 (en) 2008-02-28
DK1917018T3 (da) 2011-01-31
AU2005218729A1 (en) 2005-09-15
WO2005084610A3 (en) 2005-12-08
JP2007523925A (ja) 2007-08-23
PT1917018E (pt) 2010-12-10
ES2354076T3 (es) 2011-03-09
ES2251289A1 (es) 2006-04-16
DE602005024186D1 (de) 2010-11-25
EP1917018A2 (en) 2008-05-07
SI1917018T1 (sl) 2010-12-31

Similar Documents

Publication Publication Date Title
CY1110910T1 (el) Νεα θεραπευτικη χρηση για μια ομαδα σουλφωμενων πολυσακχαριτων
IN2012DN03632A (el)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
NO20091655L (no) Substituerte dihydropyrazoloner for behandling av kardiovaskulaere og hematologiske sykdommer
NO20073337L (no) Fremgangsmater for behandling av andedrettssykdommer ved anvendelse av antagonister av interleukin-1 reseptor type 1
EA201390060A1 (ru) Аннелированные пиримидины и триазины и их применение для лечения и/или профилактики сердечно-сосудистых заболеваний
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
JP2014505733A5 (el)
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
EA201270205A1 (ru) Фармацевтические композиции для лечения рака и других заболеваний и нарушений состояния здоровья
NO20064489L (no) Sulfaterte oligosakkarid derivater
AR082313A1 (es) Composicion farmaceutica de combinacion para tratar enfermedades o condiciones asociadas una enfermedad o condicion respiratoria
DK2794665T3 (da) Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
TWI383796B (zh) Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
EA200901113A1 (ru) Применение хитозанов для лечения воспалительных заболеваний ногтей
ZA202307290B (en) Pyrazolopyridine derivatives and uses thereof
EP2575456A4 (en) COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS
JP2011512394A5 (el)
WO2021074649A3 (en) Methods of promoting scfa production by gut microbiota
ATE481094T1 (de) Behandlung von diabetischer nephropathie
CN101536973A (zh) 一种治疗口腔疾病的环保牙膏
RU2018125252A (ru) Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции
WO2012040719A3 (en) Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders